Literature DB >> 3264383

Circulating interleukin-1 beta in patients with Kawasaki disease.

C P Maury, E Salo, P Pelkonen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3264383     DOI： 10.1056/NEJM198812223192515

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  47 in total

Review 1.  Anti-neutrophil cytoplasmic antibodies and anti-endothelial cell antibodies.

Authors:  M J Dillon; E J Tizard
Journal:  Pediatr Nephrol       Date:  1991-03       Impact factor: 3.714

2.  Intravenous immunoglobulin preparation attenuates LPS-induced production of pro-inflammatory cytokines in human monocytic cells by modulating TLR4-mediated signaling pathways.

Authors:  Kazuki Murakami; Chiaki Suzuki; Fujio Kobayashi; Atsushi Nakano; Akihiro Fujii; Kaoru Sakai; Teruaki Imada
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-05-31       Impact factor: 3.000

Review 3.  The immunoregulatory effects of IVIG in Kawasaki disease and other autoimmune diseases.

Authors:  D Y Leung
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer

Review 4.  Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease.

Authors:  T Matsubara; T Ichiyama; S Furukawa
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

5.  Changes in renal sodium transport during a systemic inflammatory response.

Authors:  Michael Eisenhut
Journal:  Pediatr Nephrol       Date:  2006-08-01       Impact factor: 3.714

6.  Serum soluble CD4 and CD8 levels in Kawasaki disease.

Authors:  S Furukawa; T Matsubara; K Tsuji; T Motohashi; K Okumura; K Yabuta
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

Review 7.  Kawasaki disease: recent advances.

Authors:  M Levin; E J Tizard; M J Dillon
Journal:  Arch Dis Child       Date:  1991-12       Impact factor: 3.791

8.  Kawasaki disease differs from anaphylactoid purpura and measles with regard to tumour necrosis factor-alpha and interleukin 6 in serum.

Authors:  S Furukawa; T Matsubara; K Yone; Y Hirano; K Okumura; K Yabuta
Journal:  Eur J Pediatr       Date:  1992-01       Impact factor: 3.183

9.  Hyponatremia and syndrome of inappropriate antidiuretic hormone secretion in kawasaki disease.

Authors:  Goh-Woon Lim; Mina Lee; Hae Soon Kim; Young Mi Hong; Sejung Sohn
Journal:  Korean Circ J       Date:  2010-10-31       Impact factor: 3.243

10.  Low-dose methotrexate therapy for intravenous immunoglobulin-resistant Kawasaki disease.

Authors:  Taek Jin Lee; Ki Hwan Kim; Jin-Kyong Chun; Dong Soo Kim
Journal:  Yonsei Med J       Date:  2008-10-31       Impact factor: 2.759
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.